跳至主要内容
临床试验/NCT01166815
NCT01166815已完成2 期

A Randomized, Double Blind, Controlled Study to Determine the Efficacy of Zinc Supplementation on Diarrhea Incidence in an Adult Population in Western Kenya.

United States Army Research Institute of Environmental Medicine5 个研究点 分布在 2 个国家目标入组 500 人开始时间: 2007年7月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
500
试验地点
5
主要终点
Determine the incidence of diarrhea in zinc vs. placebo-supplemented adults

研究概览

简要总结

Zinc deficiency is prevalent in children in developing countries. Zinc-supplementation is proven to reduce the duration and severity of childhood diarrhea in randomized controlled trials. However, despite this evidence, its efficacy to reduce diarrhea morbidity in adults remains unknown. The main objective of this study is to determine the efficacy of Zn-supplementation on diarrhea incidences in a vulnerable adult population. The study will be carried out in Kombewa division, Kisumu District and will involve 500 adults aged 18-55 years. They will be randomly assigned to receive Zn supplement (or placebo) on a daily basis over a 3 month period. Morbidity information will be collected daily for 4 months, while anthropometric measures and laboratory data will be obtained at study onset, end of supplementation and study conclusion. In addition, HIV and malaria tests will be carried out during the study as they are important confounders. The significant differences in diarrhea incidence between the Zn-group and the placebo-group will be determined using SPSS. The results are expected to provide the scientific basis and common pathway for development of an anti-diarrheal supplement for vulnerable populations such as environmental refugees, deprived and displaced persons, and troops prior to deployment.

详细描述

Diarrhea has been a major cause of morbidity, hospitalization, and loss of duty days for military personnel for centuries. In fact, diarrheal illness is the most common medical problem for U.S. troops during operational deployment. Soldiers are especially prone to diarrhea because of travel, consumption of locally procured foods (including raw vegetables and poorly-cooked meat products) and the use of nonpotable water, or ice. High rates of occurrence continue to be reported in soldiers deployed to recent conflicts. Furthermore, high morbidity rates from enteric disease have been reported by other military forces in areas of current combat operations: up to 53%-69% of Soviet troops had major gastrointestinal infections during the Afghanistan war, and up to 69% of British troops and 36% of Australian troops reported diarrhea in Iraq during Operation Safe Haven in 1991.

The region of sub-Saharan Africa, where the proposed study would be conducted, is uniquely positioned for anti-diarrheal research that can offer answers to problems of the civilian population, displaced persons and deployed soldiers or workers in remote areas. Diarrheal disease is the 4th leading cause of out-patient morbidity in Kenya, accounting for almost 5% of all new outpatient cases, with a higher prevalence in Nyanza Province - 5.4% to 7.1% of total new cases. Kisumu lies in the Nyanza Province in western Kenya, bordering Lake Victoria and populated by the Luo ethnic group. Nyanza is one of Kenya's most impoverished provinces with one of the nation's lowest immunization rates, highest infant mortality and highest prevalence of HIV (35% among adults 15-49 years old in 2000, as compared to 14% nationally). Malnutrition is common; endemic diseases include malaria, leishmaniasis, tuberculosis and schistosomiasis.

Scientists from the Centers for Disease Control and Prevention (CDC) have reported on the species of bacterial pathogens isolated from diarrhea patients in the Kisumu area: the bacterial isolates were similar to those reported in U.S. soldiers (44% Shigella; 30% Campylobacter; 14% Salmonella). However, most of the isolates (51%) were not susceptible to their antimicrobial treatment. The study by Brooks et al. (2003), reported that more than 90% of the isolates (excluding Campylobacter) were resistant to trimethoprim-sulfamethoxazole and tetracycline, and more than 80% were resistant to ampicillin.

If this alarming trend persists, and drug-resistant bacteria are identified in civilian populations, gains in disease control strategies already deployed will not be achieved, and in case of deployed members of the military or workforce, mission-impact may be severely compromised. Thus, we propose that the Kombewa Clinical Research Center (KCRC), located outside of Kisumu, would allow for testing of a novel anti-diarrheal treatment, specifically dietary zinc (Zn), in antibiotic-resistant bacteria with potential benefits to not only the deployed U.S. military and western Kenyan populations, but also other populations in Africa. Populations living in the Kombewa area will serve as potential study volunteers because of the high prevalence of antibiotic-resistant diarrhea in adults in this region.

This study will build upon the proven concept that Zn-supplementation, as an adjunct to oral rehydration, is highly protective against diarrhea in children. The results are expected to provide the scientific basis and common pathway for development of a commercially viable, multivalent, food-based, anti-diarrheal supplement for vulnerable populations such as troops prior to deployment, deprived and displaced persons. Based on a successful outcome, we would expect to attract commercial support for a final micronutrient formulation suitable for field use and expanded efficacy evaluation in pivotal studies for support of licensure. An anti-diarrheal product for adults will fill an important military, refugee population need and have dual use in the civilian sector.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female between 18 and 55 years of age
  • Written informed consent obtained from the volunteer in Dholuo, Kiswahili or English.
  • Available to participate for the study duration (approximately five months)
  • Negative pregnancy test at screening and study start
  • Not taking any vitamin/mineral supplements for the last 2 months prior to onset of the study.

排除标准

  • Profound clinical evidence of current immunosuppression or evidence of active AIDS defining illness
  • A family history of congenital or hereditary immunodeficiency
  • History of allergic reactions to zinc
  • History of any neurologic disorders or seizures
  • Acute or chronic, clinically significant pulmonary, cardiovascular, hepatic, renal functional abnormality, as determined by physical examination or laboratory screening tests
  • ALT above normal range: >60 U/L Male; >40 U/L Female
  • Creatinine above normal range: >1.5 mg/dL
  • Hemoglobin below normal range: <11.0 g/dL Male; <9.5 g/dL Female
  • Total White Cell Count below normal range <3.0 x 103/uL Male; <2.5 x 103/uL Female
  • Absolute lymphocyte count < 1.0 x 103/uL
  • Platelet count below normal range <100 x 103/uL
  • Pregnant female (positive pregnancy test) at time of screening or study start
  • History of chronic alcohol consumption and/or drug abuse
  • Use of any investigational or non-registered drugs or vaccines within 30 days preceding the first dose of the study, or planned use during the study period
  • Any chronic drug therapy to be continued during the study period
  • Simultaneous participation in any other clinical trial
  • Planning to start or unable to discontinue vitamin/mineral supplements other than those supplied by the study
  • HIV positive with current Aids defining illness or CD4 count less than 250 cells/mm3
  • Any other findings that the investigator feels would increase the risk of having an adverse outcome from participation in the trial
  • Persons having diarrhea at the time of enrollment.

结局指标

主要结局

Determine the incidence of diarrhea in zinc vs. placebo-supplemented adults

时间窗: Daily, for 104 days

Diarrhea is defined as 3 or more loose motions within a period of 24 hours. Field workers will visit each subject to record diarrhea morbidity data, daily for 104 days.

次要结局

  • Determine the number of loose stools/day/episode of diarrhea in both groups(Daily, for 104 days)
  • Determine the time to diarrhea onset in both groups(Daily, for 104 days)
  • Determine the duration of each diarrhea episode in both groups(Daily, for 104 days)

研究者

发起方
United States Army Research Institute of Environmental Medicine
申办方类型
Fed

研究点 (5)

Loading locations...

相似试验